Symbollon, Xi’an Maidefa Pharmaceutical Co. Ltd. deal

Symbollon will acquire 64% of Xi’an for $1.5 million in stock. Symbollon also will receive an option to purchase the rest of Xi’an for cash. The acquisition is expected to close next month. Symbollon ...